Related Experiment Video
Updated: Jun 19, 2026

Characterization of Vascular Morphology of Neovascular Age-Related Macular Degeneration by Indocyanine Green Angiography
Published on: August 11, 2023
Choroidal filling delay in choroidal neovascularisation due to pathological myopia
Taku Wakabayashi1, Yasushi Ikuno
1Department of Ophthalmology, Osaka University Medical School, Room E7, 2-2 Yamadaoka, Suita 565-0871, Osaka, Japan.
Abstract:
AIM To assess the choroidal thickness and choroidal circulatory changes in eyes with myopic choroidal neovascularisation (mCNV). METHODS Retrospective, consecutive, observational case series. Forty-two consecutive eyes (17 eyes with newly diagnosed mCNV and 25 eyes without CNV) were included. Choroidal circulation was evaluated by indocyanine green angiography (ICGA), and choroidal thickness was measured by spectral-domain optical coherence tomography (SD-OCT). The factors associated with mCNV were evaluated. RESULTS Sixteen (94%) of 17 eyes with mCNV and six (24%) of 25 eyes without mCNV had well-defined hypofluorescence at the macular region on arterial phase ICGA, that is, a choroidal filling delay. Older age (p<0.001), the presence of a choroidal filling delay (p<0.001) and reduced choroidal thickness (p=0.003) were significantly associated with mCNV on univariate analysis. The most important of these three factors associated with mCNV, in order of importance, were the choroidal filling delay (OR=41.5, p<0.001) and choroidal thickness (per 1 microm, OR=0.97, p=0.01). Older age was significantly associated with both choroidal filling delay (per 1 year, OR=1.16, p<0.001) and choroidal thinning (regression coefficient=-1.22, p<0.001). CONCLUSIONS Significant choroidal changes were observed in eyes with mCNV. Ischaemia-induced growth factor expression caused by decreased choroidal perfusion may be related to the development of mCNV.
Related Concept Videos
Glaucoma: Overview
Diabetic Retinopathy
Angle Closure Glaucoma: Treatment
Photoreceptors and Visual Pathways
Focusing of Light in the Eye
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
